Brief: Viewray Announces Primary Endpoint Outcome From First Prospective, Multi-Institutional Study To Deliver Ablative Doses Of Radiation To Pancreatic Cancer Patients

Viewray

24/10/2022 13:45

Oct 24 (Reuters) - ViewRay Inc  VRAY.O :
    * VIEWRAY ANNOUNCES PRIMARY ENDPOINT OUTCOME FROM FIRST
PROSPECTIVE, MULTI-INSTITUTIONAL STUDY TO DELIVER ABLATIVE DOSES
OF RADIATION TO PANCREATIC CANCER PATIENTS
    * STUDY'S PRIMARY OBJECTIVE OF LOW GRADE 3+ TOXICITY WAS MET

Source text for Eikon:  ID:nPnbGTq3Va 
Further company coverage:  VRAY.O 
 ((Reuters.Briefs@thomsonreuters.com;))